Image-guided brachytherapy for cervical cancer: A Canadian Brachytherapy Group survey

Simon Pavamani, David P. D'Souza, Lorraine Portelance, Peter S. Craighead, Andrew G. Pearce, Laurel L. Traptow, Corinne M. Doll

Research output: Contribution to journalArticle

34 Citations (Scopus)

Abstract

Purpose: To survey the current use and future plans for image-guided brachytherapy (BT) for cervical cancer by radiation oncologists in Canada. Methods and Materials: Canadian radiation oncologists treating gynecologic malignancies were identified in January 2009. A 29-item questionnaire (English and French) querying the current practice in the use of imaging in BT planning, and plans for transition to three-dimensional (3D) image guidance for BT for cervical cancer (curative intent, intact cervix), was electronically circulated. Questionnaire responses were tabulated and analyzed by respondent and by center. Results: Response rate was 62% (36 of 58 radiation oncologists), representing 71% (22 of 31) of Canadian radiation oncology centers with a gynecologic BT facility. Most of the centers were using high-dose-rate BT (68%), followed by low-dose-rate BT (23%) and pulsed dose-rate BT (10%). Main imaging used for treatment planning by center was plain X-ray (50%), computerized tomography (CT) (45%), and magnetic resonance imaging (MRI) (5%). For respondents using CT or MRI for planning, point A was the most common dose prescription point (50%), followed by gross tumor volume/clinical target volume as per Groupe Européen de Curiethérapie and the European Society for Therapeutic Radiology and Oncology guidelines (44%). For centers using plain X-rays for planning, 73% planned to transition to a 3D image-based approach, with the majority to adopt CT imaging. Eighty percent of respondents agreed that 3D image-guided BT should become standard of care for treatment of cervical cancer in Canada, and additionally support the development of national guidelines. Conclusions: Most of the Canadian radiation oncologists surveyed and Canadian cancer centers are either using 3D imaging and planning or transitioning to a 3D image-based approach within the next year. Point A remained a commonly documented prescription point. Access to MRI was very low. These results may lead to national treatment guidelines.

Original languageEnglish
Pages (from-to)345-351
Number of pages7
JournalBrachytherapy
Volume10
Issue number5
DOIs
StatePublished - Sep 1 2011
Externally publishedYes

Fingerprint

Brachytherapy
Uterine Cervical Neoplasms
Radiation Oncology
Magnetic Resonance Imaging
Guidelines
Canada
Prescriptions
Tomography
X Ray Computed Tomography
Three-Dimensional Imaging
Surveys and Questionnaires
Standard of Care
Tumor Burden
Cervix Uteri
Neoplasms
Therapeutics
X-Rays
Radiation Oncologists

Keywords

  • Cervical cancer
  • Image-guided brachytherapy
  • Pattern of practice

ASJC Scopus subject areas

  • Oncology
  • Radiology Nuclear Medicine and imaging

Cite this

Pavamani, S., D'Souza, D. P., Portelance, L., Craighead, P. S., Pearce, A. G., Traptow, L. L., & Doll, C. M. (2011). Image-guided brachytherapy for cervical cancer: A Canadian Brachytherapy Group survey. Brachytherapy, 10(5), 345-351. https://doi.org/10.1016/j.brachy.2010.12.004

Image-guided brachytherapy for cervical cancer : A Canadian Brachytherapy Group survey. / Pavamani, Simon; D'Souza, David P.; Portelance, Lorraine; Craighead, Peter S.; Pearce, Andrew G.; Traptow, Laurel L.; Doll, Corinne M.

In: Brachytherapy, Vol. 10, No. 5, 01.09.2011, p. 345-351.

Research output: Contribution to journalArticle

Pavamani, S, D'Souza, DP, Portelance, L, Craighead, PS, Pearce, AG, Traptow, LL & Doll, CM 2011, 'Image-guided brachytherapy for cervical cancer: A Canadian Brachytherapy Group survey', Brachytherapy, vol. 10, no. 5, pp. 345-351. https://doi.org/10.1016/j.brachy.2010.12.004
Pavamani, Simon ; D'Souza, David P. ; Portelance, Lorraine ; Craighead, Peter S. ; Pearce, Andrew G. ; Traptow, Laurel L. ; Doll, Corinne M. / Image-guided brachytherapy for cervical cancer : A Canadian Brachytherapy Group survey. In: Brachytherapy. 2011 ; Vol. 10, No. 5. pp. 345-351.
@article{adcbc1281797403dbfaf2b2ac3117034,
title = "Image-guided brachytherapy for cervical cancer: A Canadian Brachytherapy Group survey",
abstract = "Purpose: To survey the current use and future plans for image-guided brachytherapy (BT) for cervical cancer by radiation oncologists in Canada. Methods and Materials: Canadian radiation oncologists treating gynecologic malignancies were identified in January 2009. A 29-item questionnaire (English and French) querying the current practice in the use of imaging in BT planning, and plans for transition to three-dimensional (3D) image guidance for BT for cervical cancer (curative intent, intact cervix), was electronically circulated. Questionnaire responses were tabulated and analyzed by respondent and by center. Results: Response rate was 62{\%} (36 of 58 radiation oncologists), representing 71{\%} (22 of 31) of Canadian radiation oncology centers with a gynecologic BT facility. Most of the centers were using high-dose-rate BT (68{\%}), followed by low-dose-rate BT (23{\%}) and pulsed dose-rate BT (10{\%}). Main imaging used for treatment planning by center was plain X-ray (50{\%}), computerized tomography (CT) (45{\%}), and magnetic resonance imaging (MRI) (5{\%}). For respondents using CT or MRI for planning, point A was the most common dose prescription point (50{\%}), followed by gross tumor volume/clinical target volume as per Groupe Europ{\'e}en de Curieth{\'e}rapie and the European Society for Therapeutic Radiology and Oncology guidelines (44{\%}). For centers using plain X-rays for planning, 73{\%} planned to transition to a 3D image-based approach, with the majority to adopt CT imaging. Eighty percent of respondents agreed that 3D image-guided BT should become standard of care for treatment of cervical cancer in Canada, and additionally support the development of national guidelines. Conclusions: Most of the Canadian radiation oncologists surveyed and Canadian cancer centers are either using 3D imaging and planning or transitioning to a 3D image-based approach within the next year. Point A remained a commonly documented prescription point. Access to MRI was very low. These results may lead to national treatment guidelines.",
keywords = "Cervical cancer, Image-guided brachytherapy, Pattern of practice",
author = "Simon Pavamani and D'Souza, {David P.} and Lorraine Portelance and Craighead, {Peter S.} and Pearce, {Andrew G.} and Traptow, {Laurel L.} and Doll, {Corinne M.}",
year = "2011",
month = "9",
day = "1",
doi = "10.1016/j.brachy.2010.12.004",
language = "English",
volume = "10",
pages = "345--351",
journal = "Brachytherapy",
issn = "1538-4721",
publisher = "Elsevier Inc.",
number = "5",

}

TY - JOUR

T1 - Image-guided brachytherapy for cervical cancer

T2 - A Canadian Brachytherapy Group survey

AU - Pavamani, Simon

AU - D'Souza, David P.

AU - Portelance, Lorraine

AU - Craighead, Peter S.

AU - Pearce, Andrew G.

AU - Traptow, Laurel L.

AU - Doll, Corinne M.

PY - 2011/9/1

Y1 - 2011/9/1

N2 - Purpose: To survey the current use and future plans for image-guided brachytherapy (BT) for cervical cancer by radiation oncologists in Canada. Methods and Materials: Canadian radiation oncologists treating gynecologic malignancies were identified in January 2009. A 29-item questionnaire (English and French) querying the current practice in the use of imaging in BT planning, and plans for transition to three-dimensional (3D) image guidance for BT for cervical cancer (curative intent, intact cervix), was electronically circulated. Questionnaire responses were tabulated and analyzed by respondent and by center. Results: Response rate was 62% (36 of 58 radiation oncologists), representing 71% (22 of 31) of Canadian radiation oncology centers with a gynecologic BT facility. Most of the centers were using high-dose-rate BT (68%), followed by low-dose-rate BT (23%) and pulsed dose-rate BT (10%). Main imaging used for treatment planning by center was plain X-ray (50%), computerized tomography (CT) (45%), and magnetic resonance imaging (MRI) (5%). For respondents using CT or MRI for planning, point A was the most common dose prescription point (50%), followed by gross tumor volume/clinical target volume as per Groupe Européen de Curiethérapie and the European Society for Therapeutic Radiology and Oncology guidelines (44%). For centers using plain X-rays for planning, 73% planned to transition to a 3D image-based approach, with the majority to adopt CT imaging. Eighty percent of respondents agreed that 3D image-guided BT should become standard of care for treatment of cervical cancer in Canada, and additionally support the development of national guidelines. Conclusions: Most of the Canadian radiation oncologists surveyed and Canadian cancer centers are either using 3D imaging and planning or transitioning to a 3D image-based approach within the next year. Point A remained a commonly documented prescription point. Access to MRI was very low. These results may lead to national treatment guidelines.

AB - Purpose: To survey the current use and future plans for image-guided brachytherapy (BT) for cervical cancer by radiation oncologists in Canada. Methods and Materials: Canadian radiation oncologists treating gynecologic malignancies were identified in January 2009. A 29-item questionnaire (English and French) querying the current practice in the use of imaging in BT planning, and plans for transition to three-dimensional (3D) image guidance for BT for cervical cancer (curative intent, intact cervix), was electronically circulated. Questionnaire responses were tabulated and analyzed by respondent and by center. Results: Response rate was 62% (36 of 58 radiation oncologists), representing 71% (22 of 31) of Canadian radiation oncology centers with a gynecologic BT facility. Most of the centers were using high-dose-rate BT (68%), followed by low-dose-rate BT (23%) and pulsed dose-rate BT (10%). Main imaging used for treatment planning by center was plain X-ray (50%), computerized tomography (CT) (45%), and magnetic resonance imaging (MRI) (5%). For respondents using CT or MRI for planning, point A was the most common dose prescription point (50%), followed by gross tumor volume/clinical target volume as per Groupe Européen de Curiethérapie and the European Society for Therapeutic Radiology and Oncology guidelines (44%). For centers using plain X-rays for planning, 73% planned to transition to a 3D image-based approach, with the majority to adopt CT imaging. Eighty percent of respondents agreed that 3D image-guided BT should become standard of care for treatment of cervical cancer in Canada, and additionally support the development of national guidelines. Conclusions: Most of the Canadian radiation oncologists surveyed and Canadian cancer centers are either using 3D imaging and planning or transitioning to a 3D image-based approach within the next year. Point A remained a commonly documented prescription point. Access to MRI was very low. These results may lead to national treatment guidelines.

KW - Cervical cancer

KW - Image-guided brachytherapy

KW - Pattern of practice

UR - http://www.scopus.com/inward/record.url?scp=80052316061&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=80052316061&partnerID=8YFLogxK

U2 - 10.1016/j.brachy.2010.12.004

DO - 10.1016/j.brachy.2010.12.004

M3 - Article

C2 - 21345744

AN - SCOPUS:80052316061

VL - 10

SP - 345

EP - 351

JO - Brachytherapy

JF - Brachytherapy

SN - 1538-4721

IS - 5

ER -